Sees Q1 revenue ~$12.8B, consensus $13.13B. Expects FX to have 1.6% negative impact on Q1 sales. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ABBV: AbbVie seeing ‘significant advancements’ across entire pipeline AbbVie sees FY25 revenue ~$59B, consensus $59.07B AbbVie expects Humira access to decrease throughout 2025 AbbVie says ‘very pleased’ with progress in 2024, sees ‘strong growth’ in 2025 ABBV Earnings: AbbVie Rallies Alongside Q4 Beats